Supriya Lifescience Limited (NSE:SUPRIYA)

Supriya Lifescience Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Operating Revenue	6,706	5,704	4,609	5,300	3,912	3,116
Other Revenue	-	-	-	-	-	83.55
Revenue	6,706	5,704	4,609	5,300	3,912	3,200
Revenue Growth (YoY)	20.94%	23.74%	-13.04%	35.49%	22.25%	13.54%
Cost of Revenue	2,251	2,322	1,961	2,035	1,329	1,460
Gross Profit	4,455	3,381	2,649	3,266	2,583	1,740
Selling, General & Admin	952.74	862.26	730.21	655.81	501.41	345.47
Other Operating Expenses	983.89	758.61	628.48	465.44	350.31	323.18
Operating Expenses	2,119	1,779	1,477	1,222	919.33	732.41
Operating Income	2,335	1,602	1,172	2,043	1,664	1,008
Interest Expense	-49.08	-51.49	-30.84	-41.98	-40.8	-68.49
Interest & Investment Income	83.57	83.57	95.16	70.94	49.91	21.73
Currency Exchange Gain (Loss)	-	-	-	-	-	-4.45
Other Non Operating Income (Expenses)	-16.1	0.01	-0.02	0.1	0.13	5.18
EBT Excluding Unusual Items	2,354	1,635	1,236	2,072	1,673	962.04
Gain (Loss) on Sale of Investments	22.4	22.4	-	-	-	-
Gain (Loss) on Sale of Assets	-	-	-1.11	-	-	-
Pretax Income	2,376	1,657	1,235	2,072	1,673	962.27
Income Tax Expense	630.86	465.76	336.3	554.35	437.16	228.24
Net Income	1,745	1,191	898.57	1,518	1,236	734.03
Net Income to Common	1,745	1,191	898.57	1,518	1,236	734.03
Net Income Growth	44.93%	32.56%	-40.81%	22.83%	68.38%	86.19%
Shares Outstanding (Basic)	81	80	80	80	73	73
Shares Outstanding (Diluted)	81	80	80	80	73	73
Shares Change (YoY)	0.14%	-	-	9.97%	-	-
EPS (Basic)	21.66	14.80	11.16	18.86	16.89	10.03
EPS (Diluted)	21.66	14.80	11.16	18.86	16.89	10.03
EPS Growth	44.76%	32.62%	-40.83%	11.68%	68.38%	86.19%
Free Cash Flow	-	-323.48	-443.05	-111.03	276.48	915.37
Free Cash Flow Per Share	-	-4.02	-5.50	-1.38	3.78	12.51
Dividend Per Share	-	0.800	0.600	0.600	0.540	2.000
Dividend Growth	-	33.33%	-	11.11%	-73.00%	-
Gross Margin	66.43%	59.28%	57.46%	61.61%	66.03%	54.39%
Operating Margin	34.82%	28.09%	25.42%	38.55%	42.53%	31.50%
Profit Margin	26.02%	20.88%	19.49%	28.64%	31.59%	22.94%
Free Cash Flow Margin	-	-5.67%	-9.61%	-2.10%	7.07%	28.61%
EBITDA	2,515	1,752	1,281	2,136	1,724	1,064
EBITDA Margin	37.50%	30.72%	27.80%	40.31%	44.06%	33.26%
D&A For EBITDA	179.56	149.62	109.7	93.01	60	56.15
EBIT	2,335	1,602	1,172	2,043	1,664	1,008
EBIT Margin	34.82%	28.09%	25.42%	38.55%	42.53%	31.50%
Effective Tax Rate	26.55%	28.11%	27.23%	26.75%	26.13%	23.72%
Revenue as Reported	6,796	5,810	4,704	5,376	3,962	3,227
Advertising Expenses	-	185.39	173.92	165.03	173.8	89.56

Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.